Search
for
Sort by
Research 661–690 of 1000+
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- The Relationship Between the Use of Headscarves (Hijab) and Hair Loss (Effluvium) Prevalence in Medical Students
- ALOPESİ AREATA TEDAVİSİNDE POTANSİYEL BAZI TIBBİ BİTKİ TÜRLERİNİN İNCELENMESİ
- Microneedling with topical administration of bleomycin as a treatment method for plantar warts
- The pathogenesis of alopecia areata
- Molecular pathology of skin adnexal tumours
- Novel circRNAs from cashmere goats: Discovery, integrated regulatory network, and their putative roles in the regeneration and growth of secondary hair follicles
- Assessment of the tolerability and efficacy of supplementation containing micronized and emulsified ferric pyrophosphate in patients with iron deficiency — an observational study
- Search Advances in Lip Skin Biology and Anti-Aging Strategies
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- 0054 Treg-targeted therapies restrain disease in a murine model of alopecia areata
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- 52309 Association of venous thromboembolism in patients with alopecia areata
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases